Biomarkers · Chemical
Histamine Release Chronic Urticaria
- Also listed as
- total calcium, Histamine Release (Chronic Urticaria), serum calcium, ca, Histamine Release (Chronic Urticaria)
- LOINC codes
- 55141-6
- Tests that measure Histamine Release Chronic Urticaria
- Quest Diagnostics 4
Tests
Check the catalog code, specimen, method and preparation for every test that measures Histamine Release Chronic Urticaria. Select up to five tests to compare them side by side.
Quest Diagnostics 4 tests
Single-analyte tests
Histamine Release (Chronic Urticaria) 16838
Serum · Fasting not stated · Turnaround Set up: Tues-Fri
Quest Diagnostics catalog pageMethod and collection
- Method
- Cell Culture (CC) • Immunoassay (IA)
- Preparation
- Patients taking calcineurin inhibitors should stop their medication for 72 hours prior to draw
- Reference notes
- <16 %
Panels that include this biomarker
Chronic Urticaria Panel 3 90139
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Cell Culture (CC) • Immunoassay (IA)
- Preparation
- Overnight fasting is preferred. Patients taking calcineurin inhibitors should stop their medication for 72 hours prior to draw.
- Collection
- Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection)
- Reference notes
- See individual tests
Chronic Urticaria Panel 1 16440
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
- Preparation
- Patients taking calcineurin inhibitors should stop their medication for 72 hours prior to draw. Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks after angiography. According to the assay manufacturer Siemens: samples containing fluorescein can produce falsely depressed values. Dietary supplements containing biotin may interfere in assays and may skew results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
- Reference notes
- See individual tests
Chronic Urticaria Panel 2 (Comprehensive) 90123
5 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
- Preparation
- Patients taking calcineurin inhibitors should stop their medication for 72 hours prior to draw. Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks after angiography. According to the assay manufacturer Siemens: samples containing fluorescein can produce falsely depressed values.
- Collection
- Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection).
- Reference notes
- See individual tests
0 of 5 tests selected
Pick one moreSources
Quest Diagnostics test catalog
4 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 55141-6
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Histamine Release Chronic Urticaria
Registered studies that measure Histamine Release Chronic Urticaria, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.